Introduction
Pharmacological and behavioral studies have suggested a functional association between spinal δ-and κ-opioid antinociceptive systems and their modulation by ovarian sex steroids (Boulware et al., 2005) . Response thresholds to somatic and visceral noxious stimuli are elevated during gestation (gestational antinociception; GSA) in rats, mice, sows (Gintzler and Bohan, 1990; Iwasaki et al., 1991; Toniolo et al., 1987) and humans (Cogan and Spinnato, 1986) . Simulation of the concentration profiles of 17β-estradiol (estrogen; E 2 ) and progesterone (P) found in the blood during pregnancy (i.e. hormone-simulated pregnancy; HSP) also increases thresholds for responsiveness to aversive stimuli (HSP analgesia, HSPA). Moreover, the magnitude, temporal pattern of onset and duration and spinal opioid receptor profile of HSPA are essentially identical to those of physiological pregnancy Gintzler, 1993, 1998; Liu and Gintzler, 1999) .
In rats, pharmacological blockade of either spinal κ-opioid receptors (KOR) or δ-opioid receptors (DOR) abolishes GSA and HSPA (Dawson-Basoa and Gintzler, 1998; Liu and Gintzler, 2000) . This indicates that ovarian sex steroids can induce activation of spinal KOR and DOR analgesic systems and that both of these effects are essential for the manifestation of GSA and HSPA.
Functional interactions between spinal DOR and KOR pathways are also indicated by neurochemical analyses. Exposure of non-pregnant ovariectomized animals to pregnancy levels of E 2 and P (E 2 /P) results in a significant increase in spinal cord processing of DYN precursor intermediates (Medina et al., 1995) and in both basal and stimulated rates of lumbar dynorphin release (Gupta et al., 2001) . These findings suggest the presence of sex steroid receptors on dynorphin somata and/or terminals. Strikingly, whereas activation of spinal DOR inhibits the stimulated dynorphin release from spinal tissue of control females, DOR activation Although it has been well established that both GSA and HSPA require the participation of DOR, DYN and ovarian sex steroids, the spinal organization supporting interactions among them has not been elucidated. The most parsimonious anatomical relationship among DOR, DYN and ER consistent with their role in GSA and HSPA would be one that allows their direct interaction. Accordingly, we hypothesized that (1) spinal DOR and/or ER are coexpressed by DYN neurons and (2) their expression is affected by ovarian sex steroids. These hypotheses were tested in HSP, a condition that closely mimics the blood concentration profile of E 2 /P that occurs during gestation (Bridges, 1984) but avoids the potential confounds of the other aspects of pregnancy, e.g. changes in sensory input due to uterine distension.
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Methods
Experimental Animals
Experiments with HSP or control rats employed female Sprague-Dawley rats (Charles River, Kingston, NY; 250-300 g), which were maintained in an approved controlled environment on a 12 hr light/dark cycle. Food and water were available ad libitum. All experimental procedures were reviewed and approved by the Animal Care and Use Committees of SUNY Downstate Medical Center.
Induction of HSP. E 2 /P was administered via the subcutaneous implantation of Silastic tubing filled with either a solution of E 2 (in Sesame oil) or crystalline P (Bridges, 1984) as routinely employed by this laboratory (Dawson-Basoa and Gintzler, 1993) . Controls consisted of implants containing sesame oil (vehicle for E 2 ) and empty Silastic tubing (as a vehicle control for P). Day one of steroid hormone administration or its vehicle control was initiated at the time of ovariectomy.
Tissue preparation for immunohistochemistry
Rats were deeply anesthetized with a mixture of ketamine (68 mg/kg), xylazine (4.6 mg/kg) and acepromazine (0.9 mg/kg). Rats were perfused through the ascending aorta with 100 ml ice- 
Preparation and superfusion of spinal cord synaptosomes
The spinal vertebral column was sectioned at the intervertebral spaces above vertebrae T-12 and L-1. The lumbar spinal cord contained within this segment (L-1 to L-5; 200-250 mg) was quickly expelled by injecting ice cold saline into the caudal end. Lumbar spinal cord was homogenized in 10 ml of ice-cold 0.32 M sucrose, 5 mM Tris (pH 7.4), using a Teflon/glass homogenizer (15 strokes). Homogenate was centrifuged at 1,000 g for 5 min. The supernatant so obtained was centrifuged at 15,000 g for an additional 20 min. The resulting pellet (P2) was re-suspended in 300 µl of pre-gassed (95%O2 & 5% CO2) Krebs buffer [containing the protease inhibitors captopril (10 µM), thiorphan (0.3 µM), bestatin (10 µM), and L-leucyl-L-leucine (2 mM)], 200 µl of which was layered over 100 µl of Sephadex P-10 slurry (60%) that had been added to a superfusion chamber containing a Whatman GF/B filter at its outlet. The chamber was superfused with Krebs buffer using a Brandel SF-06 Suprafusion apparatus (Gaithersburg, MD). After a 40 min preincubation, basal release was assessed over two 6 min collections, after which 50 mM K + -evoked release was evaluated over 3 min. Subsequently, two additional cycles of release were collected, each separated by a 15 min incubation. The second release cycle was collected in presence of the delta opioid agonist D-Pen 2 ,D-Pen 5 -enkephalin (DPDPE)
(1 µM) after which the conditions for the first cycle were repeated. For all reported data, basal and evoked release in cycles 1 and 3 were indistinguishable.
Dynorphin radioimmunoassay
Superfusates containing basal release and evoked release were desalted and concentrated using reverse phase C18 Maxi-Clean cartridges (Alltech, Deerfield, IL). DYN peptide, eluted 
Immunohistochemistry
The L5, L6, S1 and S2 spinal segments were identified and mounted for sectioning. Tissue was quickly frozen and sections were cut at a nominal thickness of 10 µm on a cryostat (Bright Instruments, Huntington, UK), thawed onto Fisherfinest Capillary gap slides, (Fisher Scientific, Pittsburg, PA) and stored at -20˚C until used. In order to minimize effects of variations in staining conditions and thus maximize the reliability of our comparisons, spinal cord from two control and two experimental animals were embedded in the same block. This allowed sections from each of the four tissue samples, which could be distinguished by their orientation, to be cut, mounted and processed concomitantly. Sections were rinsed in PBS (140 mM NaCl, 10 mM Na 2 HPO 4 , 3 mM KCl, 2 mM KH 2 PO 4 ; pH = 7.4) and then co-incubated overnight at room temperature with a 1:300 dilution in PBS containing 0.3% Triton X-100 of guinea pig anti- The specificity of the antisera used in these studies was tested using absorption controls.
Controls were performed by adding 10 µg of the peptide against which the antiserum was raised to 1 ml of the diluted antiserum. In all cases, the resulting labeling was substantially reduced or abolished (Supplemental Figures 1 and 2 ).
Images were collected using either a conventional fluorescence microscope (Olympus BX-50, Tokyo, Japan) or a confocal microscope equipped with laser lines at 488 nm and 543 nm (Olympus Fluoview 1000). Confocal images were collected with a 60X, 1.4 n.a., oil immersion objective. All images are of coronal sections. Digital images were adjusted for publication (e.g.
sharpened, resized, merged, and adjusted for brightness and/or contrast) with Photoshop (Adobe, San Jose, CA) or Olympus Fluoview Viewer (Olympus). Control and experimental images were manipulated identically.
Quantitative immunocytochemical studies were performed using four HSP and four control rats; one to six sections per segment per rat were evaluated for these studies. The density of DOR-ir was evaluated using the ImageJ program. Images were collected using a 40x, 0.85 n.a.
objective, filtered using a Fourier short-pass filter (10 pixel maximum), thresholded at an intensity of 112, and the number of above-threshold pixels counted. The numbers of terminals double-labeled for DOR-ir and DYN-ir were also counted. Because automated methods proved unreliable in this case, counting was performed by eye using pairs of images obtained with a 40x, 0.85 n.a. objective.
DYN-ir neurons, ERα-ir neurons and DYN / ERα double-labeled neurons were counted by eye directly from the tissue using a 20x, 0.7 n.a. objective. Since control and HSP tissue were mounted on the same block (see above), it was not possible for the tissue to be evaluated "blindly". To validate the objectivity of our observations, we used images taken from a subset of the data. Pairs of images were made of the left and right dorsal horns from the same spinal cord (in and adjacent to the lateral substantia gelatinosa); images from the right side were identified with regard to experimental group whereas the identities of the images from the left sides were encoded. The highly significant correlation between the numbers of cells counted on the two sides (Pearson's r value=0.5526; p=.0051; 24 pairs of images from L6; ERα--ir evaluated) is strong evidence that our awareness of the experimental conditions did not influence results.
Statistical comparisons were made using the Prism software package (GraphPad, San Diego, CA). Unpaired t-tests or Fisher's exact tests were employed.
Results
This article has not been copyedited and formatted. The final version may differ from this version. Distributions of DYN and DOR. Observations were made in spinal segments L5-S2 of 4 control and 4 HSP rats. In control and HSP females, DOR-ir occurred almost entirely as fibers rather than cell somata ( Figure 1a ). Labeling was densest in the superficial dorsal horn and had a distribution similar to that of small-diameter primary afferent fibers. DOR-ir fibers were also found widely throughout the neck of the dorsal horn and the remainder of the spinal cord gray matter. These findings are consistent with previous descriptions of DOR-ir (Arvidsson et al., 1995a; Dado et al., 1993) .
DYN-ir was observed in both cell somata and nerve fibers ( Figure 1b ). Somata were concentrated in the superficial dorsal horn and in the outermost portions of nucleus proprius but were also occasionally observed in the lateral reticulated area, lamina X, and the intermediate gray of the spinal cord. Fibers were densest in the superficial dorsal horn but were also observed throughout the dorsal horn and the intermediate gray. They were only rarely observed in the ventral horn. Significantly more DYN-ir profiles were present in L5 of HSP rats (14.42 ± 0.95 profiles/section in HSP rats vs. 10.46 ± 0.91 profiles/section in control rats, p=.0042; Figure   2 ). The same was also found in the L6 segment (11.61 ± 1.01 profiles/section in HSP rats vs.
8.38 ± 0.73 profiles/section in control rats, p=.0122). However, no significant differences were observed for S1 or S2 (S1: 8.91 ± 0.74 HSP vs. 6.96 ± 0.66 control, p=0.0542; S2: 7.22 ± 0.47 HSP vs. 6.78 ± 0.54 control, p=0.5502).
Coexpression of DYN AND DOR. The regulation of DYN release by activation of DOR
suggested that DORs might be expressed by DYN neurons. Consistent with previous observations, (Arvidsson et al., 1995a; Dado et al., 1993) , we did not observe DOR expression by somata. However, DYN-ir terminals frequently ( (following a three min pretreatment), the K + -evoked increase in the rate of DYN release was reduced to 6.3pg/6 min, a decrement of 4.8 pg (43%: Figure 5 , open bar; p=0.03; n=3 ).
Co-expression of ERα-and DYN. As stated above, spinal KOR activity is essential to GSA and HSPA (Dawson-Basoa and Gintzler, 1998; Liu and Gintzler, 1999; Liu and Gintzler, 2000) This article has not been copyedited and formatted. The final version may differ from this version. (Medina et al., 1993a; Medina et al., 1993b) and DYN release (Gupta et al., 2001 ).
Thus we hypothesize that ovarian steroids affect the function of spinal DYN-ergic neurons. The most parsimonious mechanism would be that DYN neurons express steroid receptors. In order to explore this possibility, we examined expression of ERα by DYN neurons.
In dorsal horn of control female rats we observed a moderate number of ERα-ir structures that appeared to be neuronal nuclei and that were concentrated in the superficial dorsal horn and lateral reticulated area (lamina V) ( Figure 6 ). In HSP females, ERα-ir cells were also found in the superficial dorsal horn and lamina V; in addition they were now lightly distributed throughout the neck of the dorsal horn, the intermediate gray and the ventral horn. The number of ERα-ir nuclei was significantly higher (30%) in L5, L6 and S1 of HSP animals (p<0.02 in all cases; Figure 7 ). No significant difference was observed in the S2 segment (p>0.4).) DYN-ir neurons frequently co-expressed ERα-ir ( Figure 6 ). The number of DYN-ir neurons that co-expressed ERα-ir was significantly higher in L6 and S1 of HSP animals than in control animals (L6: 3.26 ± 0.32 DYN-ER profiles/section for HSP rats vs. 1.63 ± 0.18 profiles/section for control rats, p<0.0001; S1: 1.78 ± 0.34 DYN-ER profiles/section for HSP rats vs. 0.92 ± 0.17 profiles/section for control rats, p<0.02: Figure 8a ). No significant differences were observed for L5 or S2 (p>0.4 in both cases). The proportion of DYN-ir neurons that expressed ERα-ir was also significantly higher in the L6 segment (p=0.03, Fisher's exact test: Figure 8b ) but no others.
There was no significant difference in the proportion of ERα-ir profiles that were double-labeled for DYN-ir in any segment (p>0.15 in all cases).
This article has not been copyedited and formatted. The final version may differ from this version. (Medina et al., 1993a; Medina et al., 1993b) This article has not been copyedited and formatted. The final version may differ from this version. Previous studies by one of us (ARG) have found that afferent input from the uterus contributes to GSA: GSA is significantly reduced by sectioning of the hypogastric nerve (Gintzler et al., 1983) , which carries afferent input from the rostral uterus to the upper lumbar spinal cord (L1-L3) (Berkley et al., 1993) . L6 and S1 receive afferent input from the caudal uterus (including the cervix) via the pelvic nerve (Berkley et al., 1993) . Thus our present findings suggest either that the present observations are secondary to changes in the upper lumbar spinal cord, or that that sectioning of the pelvic nerve may also affect GSA and HSPA.
The present studies employed profile counting rather than stereologically unbiased methods to quantify changes in immunohistochemical staining in spinal tissue of HSP rats, due to the difficulty using either the physical or optical disector methods in the sections used in these studies. Profile counting is vulnerable to mis-estimation of cell numbers if the sizes of cells increase (Reed and Howard, 1998) However, it appears unlikely that this was the case since there were no significant differences (either for DYN-ir or ERα-ir) in the cross-sectional areas of cell profiles (for DYN) or nuclear profiles (for ERα-ir) between control and HSP rats (p>0.57 in both cases). Thus it appears that the present results represent differences in cell numbers as well as differences in cell profiles.
Earlier studies revealed a variety of interactions between opioid systems and ERs. ER regulates synthesis and secretion of the DOR ligand methionine-enkephalin (Amandusson et al., 1999; Low et al., 1989; Romano et al., 1988) . ER-mediated regulation of β-endorphin content and secretion is also well established (Lapchak, 1991; Nakano et al., 1991) .
Additionally, regulation by E 2 and ERα of the µ-opioid receptor density in the hypothalamus (Joshi et al., 1993; Mateo et al., 1992) and µ-opioid receptor internalization (Micevych et al., 2003) has been reported. The present demonstration of an association of ERs (ERα) with DYNergic neurons in combination with the demonstrated influence of the estrous cycle on spinal KOR (Chang et al., 2000) emphasizes the influence of ovarian sex steroids on endogenous opioids.
Many of the actions of E 2 are mediated via protein kinase A. (Auger et al., 2001; Gu and Moss, 1996; Mize and Alper, 2002) . Additionally, E 2 (via ERα) modulates mitogen-activated protein kinase activation (Zhang et al., 2002) and phosphorylation (activation) of extracellular signalregulated kinase 1/2 (ERK1/2) is induced by estradiol (Setalo et al., 2002) . We speculate that the enhanced release of spinal DYN noted during gestation and HSP (Gupta et al., 2001) receptors (Boulware et al., 2005) . Thus, it is possible that estrogen via membrane ERs are able to directly affect the firing of DYN neurons.
The second notable finding is that DYN-ir fibers in the spinal cord dorsal horn and intermediate gray matter co-express DOR-ir, suggesting that DOR agonists modulate DYN release by acting directly on DYN nerve terminals. We (ARG, DG) previously reported that evoked release of DYN from minced spinal cord tissue was dose-dependently inhibited by the DOR agonist DPDPE (Gupta et al., 2001 ). The minced spinal cord preparation used in those studies contained both DYN somata and DYN terminals, precluding differentiation between these two sites of action. However, somata are not present in the spinal cord synaptosomal preparation used in the current study. Thus, the most parsimonious explanation for ability of DPDPE to inhibit DYN release from spinal synaptosomes would be direct negative modulation of DYN release by terminal DORs. This confirms the functional relevance of our anatomical findings.
Expression of DOR by DYN terminals provides a mechanism by which DOR activation can modulate DYN release selectively at different synapses. The latter could allow pain to be modulated during pregnancy with a great deal of anatomical specificity. Interestingly, modulation of spinal DYN release by DOR reverses from inhibition to activation during HSP (Gupta et al., 2001) , indicating its dependence on physiological state.
The present findings cannot directly explain some of the more striking characteristics of HSPA,
i.e., the requirement for concomitant activation of both spinal DOR and KOR (Dawson-Basoa and Gintzler, 1998) and the shift from inhibition to enhancement of DOR modulation of spinal DYN release (Gupta et al., 2001) . Nevertheless, the spatial relationships we observed among spinal DOR, KOR and ERα justify concluding that they directly interact. We hypothesize that
ERα is expressed by neurons co-expressing DYN and DOR; the effects of ER activation on
This article has not been copyedited and formatted. The final version may differ from this version. antinociception in female rats (Liu, et al., 2007) . Thus, it is tempting to speculate that administration to the lumbosacral cord of appropriate regimens of ovarian sex steroids, alone or in combination with a DOR agonist (which would release DYN after treatment with ovarian sex steroids; Gupta, et al., 2001 ) could represent a novel pharmacotherapeutic approach i to treat chronic pelvic pain in women. 
